系统性红斑狼疮的治疗
Treatment of systemic lupus erythematosus.
作者信息
McKeon Kathryn P, Jiang Simon H
机构信息
Department of Renal Medicine, The Canberra Hospital.
Department of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra.
出版信息
Aust Prescr. 2020 Jun;43(3):85-90. doi: 10.18773/austprescr.2020.022. Epub 2020 Jun 2.
Abstract
Systemic lupus erythematosus should be suspected in individuals with one or more classic symptoms. Diagnosis is made clinically and supported by serology Reducing sun exposure is central to the management of lupus Hydroxychloroquine is first-line treatment unless contraindicated and is useful in almost all manifestations of lupus. Other treatments are titrated against type and severity of organ involvement Monoclonal antibodies have a limited role in the management of lupus
摘要
有一个或多个典型症状的个体应怀疑患有系统性红斑狼疮。诊断基于临床症状，并得到血清学检查的支持。减少阳光照射是狼疮治疗的核心。羟氯喹是一线治疗药物，除非有禁忌，对几乎所有狼疮表现都有效。其他治疗方法根据器官受累的类型和严重程度进行调整。单克隆抗体在狼疮治疗中的作用有限。
相似文献
1
Treatment of systemic lupus erythematosus.系统性红斑狼疮的治疗
Aust Prescr. 2020 Jun;43(3):85-90. doi: 10.18773/austprescr.2020.022. Epub 2020 Jun 2.
2
Interventions for cutaneous disease in systemic lupus erythematosus.治疗系统性红斑狼疮皮肤病变的干预措施。
Cochrane Database Syst Rev. 2021 Mar 9;3(3):CD007478. doi: 10.1002/14651858.CD007478.pub2.
3
Anifrolumab in systemic lupus erythematosus.阿尼鲁单抗治疗系统性红斑狼疮。
Drugs Today (Barc). 2023 Feb;59(2):53-61. doi: 10.1358/dot.2023.59.2.3521876.
4
Hydroxychloroquine modulates elevated expression of S100 proteins in systemic lupus erythematosus.羟氯喹调节系统性红斑狼疮中 S100 蛋白的异常表达。
Lupus. 2019 Jun;28(7):826-833. doi: 10.1177/0961203319846391. Epub 2019 May 8.
5
French protocol for the diagnosis and management of systemic lupus erythematosus.法国系统性红斑狼疮诊断和治疗方案。
Rev Med Interne. 2024 Sep;45(9):559-599. doi: 10.1016/j.revmed.2024.07.006. Epub 2024 Aug 26.
6
Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.米帕林与羟氯喹联合治疗系统性红斑狼疮伴难治性皮肤和关节活动患者。
Lupus. 2018 Sep;27(10):1718-1722. doi: 10.1177/0961203318768877. Epub 2018 Apr 10.
7
Systemic lupus erythematosus.系统性红斑狼疮
BMJ Clin Evid. 2007 Apr 1;2007:1123.
8
Cutaneous lupus erythematosus: issues in diagnosis and treatment.皮肤红斑狼疮：诊断与治疗中的问题
Am J Clin Dermatol. 2009;10(6):365-81. doi: 10.2165/11310780-000000000-00000.
9
Systemic lupus erythematosus.系统性红斑狼疮
BMJ Clin Evid. 2009 Jul 24;2009:1123.
10
Initial hydroxychloroquine monotherapy in systemic lupus erythematosus: report of three cases.羟氯喹单药治疗系统性红斑狼疮：三例报告。
Mod Rheumatol Case Rep. 2021 Jul;5(2):259-264. doi: 10.1080/24725625.2021.1881215. Epub 2021 Feb 18.
引用本文的文献
1
Gene polymorphisms associated with immunosuppressant adverse effects in systemic lupus erythematosus: a narrative review.系统性红斑狼疮中与免疫抑制剂不良反应相关的基因多态性：一项叙述性综述
Front Genet. 2025 Jun 24;16:1594648. doi: 10.3389/fgene.2025.1594648. eCollection 2025.
2
Multi-omics integration identifies NK cell-mediated cytotoxicity as a therapeutic target in systemic lupus erythematosus.多组学整合确定自然杀伤细胞介导的细胞毒性是系统性红斑狼疮的一个治疗靶点。
Front Immunol. 2025 May 13;16:1580540. doi: 10.3389/fimmu.2025.1580540. eCollection 2025.
3
Evolving Treatment Strategies for Systemic Lupus Erythematosus in Clinical Practice: A Narrative Review.临床实践中系统性红斑狼疮不断发展的治疗策略：一项叙述性综述
Cureus. 2024 Dec 3;16(12):e75062. doi: 10.7759/cureus.75062. eCollection 2024 Dec.
4
Combination of Methotrexate and Resveratrol Reduces Pro-Inflammatory Chemokines in Human THP-1 Cells.甲氨蝶呤与白藜芦醇联合使用可降低人THP-1细胞中的促炎趋化因子水平。
J Inflamm Res. 2024 Nov 2;17:8085-8098. doi: 10.2147/JIR.S482503. eCollection 2024.
5
Deciphering Mechanisms, Prevention Strategies, Management Plans, Medications, and Research Techniques for Strokes in Systemic Lupus Erythematosus.系统性红斑狼疮中风的发病机制、预防策略、管理方案、药物治疗及研究技术解析
Medicines (Basel). 2024 Jul 31;11(7):15. doi: 10.3390/medicines11070015.
6
Advances in Systemic Lupus Erythematosus Treatment With Monoclonal Antibodies: A Mini-Review.单克隆抗体治疗系统性红斑狼疮的研究进展：一篇综述。
Cureus. 2024 Jul 8;16(7):e64090. doi: 10.7759/cureus.64090. eCollection 2024 Jul.
7
Reevaluating Biota Alteration: Reframing Environmental Influences on Chronic Immune Disorders and Exploring Novel Therapeutic Opportunities.重新评估生物群改变：重新构建环境对慢性免疫性疾病的影响，并探索新的治疗机会。
Yale J Biol Med. 2024 Jun 28;97(2):253-263. doi: 10.59249/VUNF1315. eCollection 2024 Jun.
8
Targeting TYK2 for Fighting Diseases: Recent Advance of TYK2 Inhibitors.靶向 TYK2 治疗疾病：TYK2 抑制剂的最新进展。
Curr Med Chem. 2024;31(20):2900-2920. doi: 10.2174/0929867330666230324163414.
9
Potential Therapeutic Application and Mechanism of Action of Stem Cell-Derived Extracellular Vesicles (EVs) in Systemic Lupus Erythematosus (SLE).干细胞衍生的细胞外囊泡 (EVs) 在系统性红斑狼疮 (SLE) 中的潜在治疗应用和作用机制。
Int J Mol Sci. 2024 Feb 19;25(4):2444. doi: 10.3390/ijms25042444.
10
Systemic lupus erythematosus and Down syndrome: a case report and literature review.系统性红斑狼疮与唐氏综合征：一例报告及文献综述
Ann Med Surg (Lond). 2024 Jan 3;86(2):1112-1115. doi: 10.1097/MS9.0000000000001607. eCollection 2024 Feb.
本文引用的文献
1
Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial.I型干扰素抑制剂阿尼鲁单抗治疗活动性系统性红斑狼疮（TULIP-1）：一项随机、对照、3期试验
Lancet Rheumatol. 2019 Dec;1(4):e208-e219. doi: 10.1016/S2665-9913(19)30076-1. Epub 2019 Nov 11.
2
Trial of Anifrolumab in Active Systemic Lupus Erythematosus.阿尼鲁单抗治疗活动性系统性红斑狼疮的试验。
N Engl J Med. 2020 Jan 16;382(3):211-221. doi: 10.1056/NEJMoa1912196. Epub 2019 Dec 18.
3
Immunomodulatory drugs in pregnancy and lactation.妊娠和哺乳期的免疫调节药物。
Aust Prescr. 2019 Jun;42(3):97-101. doi: 10.18773/austprescr.2019.026. Epub 2019 Jun 3.
4
Association between NSAID use and mortality risk in patients with end-stage renal disease: a population-based cohort study.非甾体抗炎药使用与终末期肾病患者死亡风险之间的关联：一项基于人群的队列研究。
Clin Epidemiol. 2019 May 31;11:429-441. doi: 10.2147/CLEP.S204322. eCollection 2019.
5
Immunosuppressive treatment for proliferative lupus nephritis.增殖性狼疮性肾炎的免疫抑制治疗
Cochrane Database Syst Rev. 2018 Jun 29;6(6):CD002922. doi: 10.1002/14651858.CD002922.pub4.
6
Hydroxycloroquine blood concentration in lupus nephritis: a determinant of disease outcome?羟氯喹在狼疮肾炎中的血药浓度：疾病转归的决定因素？
Nephrol Dial Transplant. 2018 Sep 1;33(9):1604-1610. doi: 10.1093/ndt/gfx318.
7
Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial.肠溶型麦考酚钠与硫唑嘌呤治疗活动期系统性红斑狼疮的随机临床试验
Ann Rheum Dis. 2017 Sep;76(9):1575-1582. doi: 10.1136/annrheumdis-2016-210882. Epub 2017 Apr 27.
8
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients.个性化免疫监测揭示了对狼疮患者进行分层的分子网络。
Cell. 2016 Jun 2;165(6):1548-1550. doi: 10.1016/j.cell.2016.05.057.
9
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).关于氯喹和羟氯喹视网膜病变筛查的建议（2016 年修订版）。
Ophthalmology. 2016 Jun;123(6):1386-94. doi: 10.1016/j.ophtha.2016.01.058. Epub 2016 Mar 16.
10
The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study.增加羟氯喹（HCQ）剂量对难治性皮肤红斑狼疮（CLE）患者的影响：一项开放标签前瞻性初步研究。
J Am Acad Dermatol. 2016 Apr;74(4):693-9.e3. doi: 10.1016/j.jaad.2015.09.064. Epub 2016 Feb 3.
Zotero 插件